MINA THERAPEUTICS LIMITED

Active London

Research and experimental development on biotechnology

28 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MINA THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 7 Mar 2008 Active London, United Kingdom 28 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 25 Jul 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 16 Apr 2026 Next due 21 Mar 2027 10 months remaining
Net assets £-52M £6M 2024 year on year
Total assets £5M £4M 2024 year on year
Total Liabilities £58M £2M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Translation & Innovation Hub 84 Wood Lane London W12 0BZ United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for MINA THERAPEUTICS LIMITED (06527890), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 7 Mar 2008. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2013–2024)

Cash in Bank

£761.55k

Decreased by £2.97M (-80%)

Net Assets

-£52.48M

Decreased by £5.63M (-12%)

Total Liabilities

£57.66M

Increased by £1.72M (+3%)

Turnover

N/A

Employees

28

Decreased by 1 (-3%)

Debt Ratio

1113%

Increased by 497 (+81%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Galantine-heller, StephanieDirectorFrenchEngland4317 Feb 2025Active
Yael Gruenbaum-cohenDirectorIsraeliIsrael4917 Feb 2025Active

Shareholders

Shareholders (1)

Mina (holdings) Limited
0.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

MINA THERAPEUTICS LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Apr 2026Confirmation StatementConfirmation statement made on 2026-03-07 with no updates
16 Apr 2026OfficersAppointment of Stephanie Galantine-Heller as director
5 Jan 2026OfficersChange to director Dr. Norbert Wolfgang Bischofberger on 2026-01-05
24 Dec 2025OfficersChange to director Mr Robert Kopple on 2025-12-24
24 Dec 2025OfficersChange to director Mr Robert Charles Kopple on 2025-12-24
16 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-03-07 with no updates

16 Apr 2026 Officers

Appointment of Stephanie Galantine-Heller as director

5 Jan 2026 Officers

Change to director Dr. Norbert Wolfgang Bischofberger on 2026-01-05

24 Dec 2025 Officers

Change to director Mr Robert Kopple on 2025-12-24

24 Dec 2025 Officers

Change to director Mr Robert Charles Kopple on 2025-12-24

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-07 with no updates

1 weeks ago on 16 Apr 2026

Appointment of Stephanie Galantine-Heller as director

1 weeks ago on 16 Apr 2026

Change to director Dr. Norbert Wolfgang Bischofberger on 2026-01-05

3 months ago on 5 Jan 2026

Change to director Mr Robert Kopple on 2025-12-24

4 months ago on 24 Dec 2025

Change to director Mr Robert Charles Kopple on 2025-12-24

4 months ago on 24 Dec 2025